학술논문
Safety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-controlled, dose-ranging trial
Document Type
Article
Author
Robbins, J.A.; Huang, Q.; Dubey, S.; Crumley, T.; Cote, J.; Luk, J.; Sachs, J.R.; Simon, J.; Hardalo, C.; Zhao, X.; Wnek, R.; Lai, E.; Annunziato, P.; Guris, D.; Stoch, S.A.; Tait, D.; Rutkowski, K.; Park, H.; Cope, A.; Schwab, R.; O'Reilly, T.; Howitt, W.J.; Rondon, J.C.; Hernandez-Illas, M.; Smith, W.
Source
In: eBioMedicine . (eBioMedicine, August 2022, 82)
Subject
Language
English
ISSN
23523964